Atomoxetine
- Product NDC
- 64380-478
- 11-digit product format
- 643800478
- Labeler code
- 64380
- Product ID
- 64380-478_27a196c2-92d8-4c4f-97e5-210ae78dedbe
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atomoxetine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Strides Pharma Science Limited
- Application
- ANDA079021
- Marketing category
- ANDA
- Marketing start
- 2025-07-01
- Substance
- ATOMOXETINE HYDROCHLORIDE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A079021-001 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2021-02-18 | |
| A079021-002 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE | CAPSULE / ORAL | AB | 2021-02-18 | |
| A079021-003 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2021-02-18 | |
| A079021-004 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE / ORAL | AB | 2021-02-18 | |
| A079021-005 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE / ORAL | AB | 2021-02-18 | |
| A079021-006 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE | CAPSULE / ORAL | AB | 2021-02-18 | |
| A079021-007 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2021-02-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A079021-001 | AB |
| A079021-002 | AB |
| A079021-003 | AB |
| A079021-004 | AB |
| A079021-005 | AB |
| A079021-006 | AB |
| A079021-007 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079021-001 | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2021-02-18 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079021-002 | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE | CAPSULE / ORAL | AB | 2021-02-18 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079021-003 | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2021-02-18 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079021-004 | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE / ORAL | AB | 2021-02-18 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079021-005 | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE / ORAL | AB | 2021-02-18 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079021-006 | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE | CAPSULE / ORAL | AB | 2021-02-18 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079021-007 | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2021-02-18 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079021-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079021-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079021-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079021-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079021-005 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079021-006 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079021-007 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atomoxetine | ATOMOXETINE | Bryant Ranch Prepack | 47cd1d85-fbc1-4309-9365-58bacf108f5b | 2026-06-16 | Boxed warning, Warnings, Adverse reactions | 079021 ANDA079021 |
| Atomoxetine | ATOMOXETINE | Bryant Ranch Prepack | b00eb367-d7cc-42fa-91af-a1a5f90dbb41 | 2025-12-03 | Boxed warning, Warnings, Adverse reactions | 079021 ANDA079021 |
| Atomoxetine | ATOMOXETINE | Bryant Ranch Prepack | bb2c12e4-563c-417e-bee1-6d8c51e75af4 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | 079021 ANDA079021 |
| Atomoxetine | ATOMOXETINE | Bryant Ranch Prepack | c5e9e305-8d99-4234-b531-6ade177768b7 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | 079021 ANDA079021 |
| Atomoxetine | ATOMOXETINE | Bryant Ranch Prepack | 1d26aff3-72a7-4a5b-a6fe-44dc8a08b196 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | 079021 ANDA079021 |
| Atomoxetine | ATOMOXETINE | Bryant Ranch Prepack | 9c1f858c-8721-49e3-be8b-bf180e89ff42 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | 079021 ANDA079021 |
| Atomoxetine | ATOMOXETINE | Bryant Ranch Prepack | bbb2a8f6-0816-47b1-830a-ef23e97d498f | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | 079021 ANDA079021 |
| Atomoxetine | ATOMOXETINE | Bryant Ranch Prepack | c6542d69-d0a2-4663-9172-943f9f6f5325 | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | 079021 ANDA079021 |
| Atomoxetine | ATOMOXETINE | Strides Pharma Science Limited | 2614df7e-0b16-4b03-883e-141d4ec34b35 | 2025-08-10 | Boxed warning, Warnings, Adverse reactions | 079021 ANDA079021 64380-478 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Atomoxetine
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ATOMOXETINE HYDROCHLORIDE | 100 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 57WVB6I2W0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2614df7e-0b16-4b03-883e-141d4ec34b35 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0d16f546-db6a-1939-50fc-d06382424c97 | Product name | 4 | 20210903 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64380-478-01 | Atomoxetine | 30 in 1 BOTTLE, PLASTIC | CAPSULE | 30 | 1 | |
| 64380-478-02 | Atomoxetine | 500 in 1 BOTTLE, PLASTIC | CAPSULE | 500 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 64380-478-01 | EA - Each | 64380-478 | f2829af6-a437-437f-ba75-82a7fb767478 | 1 | 2025-09-12 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 608139 | atomoxetine HCl 100 MG Oral Capsule | PSN | c6542d69-d0a2-4663-9172-943f9f6f5325 | 100 |
| 608139 | atomoxetine 100 MG Oral Capsule | SCD | c6542d69-d0a2-4663-9172-943f9f6f5325 | 100 |
| 608139 | atomoxetine 100 MG (as atomoxetine HCl) Oral Capsule | SY | c6542d69-d0a2-4663-9172-943f9f6f5325 | 100 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 64380-478-01 | 64380047801 | 30 CAPSULE in 1 BOTTLE, PLASTIC (64380-478-01) | 30 capsule | 2025-07-01 | No | No | Current |
| 64380-478-02 | 64380047802 | 500 CAPSULE in 1 BOTTLE, PLASTIC (64380-478-02) | 500 capsule | 2025-07-01 | No | No | Current |